Secondary care : Please note that though there may be drugs listed with a Formulary status in this section, you should refer to the Acute Trust's antibiotic policy found here as there are some restrictions, which require microbiology approval before they can be supplied by Pharmacy.
Primary Care - refer to local guidance for more advice
Commissioned by NHS England. Third or fourth line to other HIV therapy
Darunavir and Cobicistat (Rezolsta®)
Formulary
Commissioned by NHS England.
Fosamprenavir
Formulary
Commissioned by NHS England.
Indinavir
Formulary
Commissioned by NHS England.
Lopinavir and Ritonavir (Kaletra®)
Formulary
Commissioned by NHS England.
Nelfinavir
Formulary
Commissioned by NHS England.
Ritonavir
Formulary
Commissioned by NHS England.
Saquinavir
Formulary
Commissioned by NHS England.
Tipranavir
Formulary
Commissioned by NHS England. Third or fourth line to other HIV therapy
05.03.01
Non-nucleoside reverse transcriptase inhibitors
05.03.01
Other antiretrovirals
05.03.01
Pharmacokinetic enhancers of antiretrovirals
05.03.01
Combination Products
....
Non Formulary Items
Amprenavir (Agenerase®)
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Secondary care only, not to be prescribed in primary care.
Specialist initiation with shared care guidance
Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline
Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline
Considered suitable for primary care prescribing following specialist initiation/recommendation.
Considered appropriate for prescribing in both secondary and primary care.
Suitable for initiation in primary care.
